Is Aridis Pharmaceuticals, Inc. (ARDS) a Buy, Sell, or Hold?
OTC : ARDS
Aridis Pharmaceuticals, Inc. — Institutional Ownership
$0.0001 USD
$0 (0.0%)
- Volume
- 40.1K
- Average Volume
- 15.13K
- Market Capitalization
- $4.46K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.05
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.32
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Armistice Capital, LLC | 5.1M | 11.43% |
| 2026-02-17 | Armistice Capital, LLC | 5.1M | 11.43% |
| 2025-08-14 | Armistice Capital, LLC | 5.1M | 11.43% |
| 2025-05-15 | Armistice Capital, LLC | 5.1M | 11.43% |
| 2025-02-14 | Armistice Capital, LLC | 5.1M | 11.43% |
| 2023-03-20 | Lind Global Partners II LLC | 3M | 8.30% |
| 2023-03-20 | Jeff Easton | 3M | 8.30% |
| 2023-03-20 | Lind Global Partners II LLC | 3M | 8.30% |
| 2023-03-20 | Lind Global Fund II LP | 3M | 8.30% |
| 2023-03-20 | Lind Global Fund II LP | 3M | 8.30% |
| 2023-03-20 | Jeff Easton | 3M | 8.30% |
| 2023-02-14 | Armistice Capital, LLC | 3M | 9.99% |
| 2023-02-14 | Steven Boyd | 3M | 9.99% |
| 2023-02-14 | Armistice Capital, LLC | 3M | 9.99% |
| 2023-02-14 | Steven Boyd | 3M | 9.99% |
| 2022-12-19 | Cystic Fibrosis Foundation | 5.17M | 19.90% |
| 2022-12-19 | Cystic Fibrosis Foundation | 5.17M | 19.90% |
| 2021-07-27 | Name of Reporting Person | 7.0 | 8.00% |
| 2021-07-27 | Name of Reporting Person | 3.0 | 4.00% |
| 2021-04-01 | John Francis | 676.86K | 6.10% |
| 2021-04-01 | John Francis | 676.86K | 6.10% |
| 2021-04-01 | Catalysis Partners, LLC | 676.86K | 6.10% |
| 2021-04-01 | Catalysis Partners, LLC | 676.86K | 6.10% |
| 2021-04-01 | Francis Capital Management, LLC | 676.86K | 6.10% |
| 2021-04-01 | Francis Capital Management, LLC | 676.86K | 6.10% |
ARDS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $1.18 | 18.78M | $22.16M | $4.88M | $6.13M | $23.41M |
| 2021-12-31 | $2.33 | 12.29M | $28.64M | $19.99M | $5.98M | $14.63M |
| 2020-12-31 | $6.07 | 9.17M | $55.65M | $8.23M | $715K | $48.14M |
| 2019-12-31 | $4.45 | 8.46M | $37.64M | $20.9M | -$ | $16.74M |
| 2018-12-31 | $11.09 | 3.15M | $34.9M | $24.24M | -$ | $10.66M |
| 2017-12-31 | $13.00 | 7.89M | $102.57M | $25.1M | -$ | $77.48M |
| 2016-12-31 | $13.00 | 7.89M | $102.57M | $22.29M | -$ | $80.28M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-09-30 | $0.10 | 37.43M | $3.82M | $35000 | $4.84M | $8.63M |
| 2023-06-30 | $0.22 | 36.08M | $7.93M | $19000 | $6.3M | $14.21M |
| 2023-03-31 | $0.31 | 30.41M | $9.55M | $1.32M | $3.95M | $12.18M |
| 2022-12-31 | $1.18 | 18.24M | $21.52M | $4.88M | $6.13M | $22.78M |
| 2022-09-30 | $0.93 | 17.7M | $16.46M | $1.89M | $14.08M | $28.66M |
| 2022-06-30 | $1.10 | 17.7M | $19.47M | $6.32M | $13M | $26.15M |
| 2022-03-31 | $1.76 | 17.7M | $31.15M | $12.48M | $12.99M | $31.67M |
| 2021-12-31 | $2.33 | 14.5M | $33.78M | $19.99M | $5.98M | $19.78M |
| 2021-09-30 | $3.68 | 12.45M | $45.83M | $18.22M | -$ | $27.61M |
| 2021-06-30 | $7.40 | 11.23M | $83.13M | $3.59M | -$ | $79.54M |
| 2021-03-31 | $5.90 | 10.23M | $60.36M | $10.47M | $715K | $50.6M |
| 2020-12-31 | $6.07 | 9.9M | $60.11M | $8.23M | $715K | $52.6M |